Neeraj Tomar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Neeraj Tomar has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Amitabh Biswas
Department of Forensic Sciences, School of Forensic Sciences, Galgotias University, Greater, India
1 shared publication - Bhavuk Garg
Department of Orthopaedics, All India Institute of Medical Sciences, New Delhi 110029, Delhi, India
1 shared publication - Nishank Mehta
Department of Orthopaedics, All India Institute of Medical Sciences, New Delhi, India
1 shared publication - Rajesh Malhotra
Department of Orthopaedics, All India Institute of Medical Sciences, New Delhi 110029, Delhi, India
1 shared publication
Latest Publications
- 1 April 2022
- Published by Wolters Kluwer Health in JBJS Reviews
- Vol. 10 (4)
Understanding Musculoskeletal Disorders Through Next-Generation Sequencing
» An insight into musculoskeletal disorders through advancements in next-generation sequencing (NGS) promises to maximize benefits and improve outcomes through improved genetic diagnosis. » The primary use of whole exome sequencing (WES) for musculoskeletal disorders is to identify functionally relevant variants. » The current evidence has shown the superiority of NGS over conventional genotyping for identifying novel and rare genetic variants in patients with musculoskeletal disorders, due to its high throughput and low cost. » Genes identified in patients with scoliosis, osteoporosis, osteoarthritis, and osteogenesis imperfecta using NGS technologies are listed for further reference.
- 1 April 2022
- Published by Wolters Kluwer Health in JBJS Reviews
- Vol. 10 (4)
Understanding Musculoskeletal Disorders Through Next-Generation Sequencing
» An insight into musculoskeletal disorders through advancements in next-generation sequencing (NGS) promises to maximize benefits and improve outcomes through improved genetic diagnosis. » The primary use of whole exome sequencing (WES) for musculoskeletal disorders is to identify functionally relevant variants. » The current evidence has shown the superiority of NGS over conventional genotyping for identifying novel and rare genetic variants in patients with musculoskeletal disorders, due to its high throughput and low cost. » Genes identified in patients with scoliosis, osteoporosis, osteoarthritis, and osteogenesis imperfecta using NGS technologies are listed for further reference.